Trials / Active Not Recruiting
Active Not RecruitingNCT04751084
Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment
Use of Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment With High and Low Uterine Contraction Frequency Prior to Embryo Transfer: A Prospective Double-blinded Randomized Controlled Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 675 (actual)
- Sponsor
- Chinese University of Hong Kong · Academic / Other
- Sex
- Female
- Age
- 42 Years
- Healthy volunteers
- Not accepted
Summary
To determine if the use of Buscopan in patients undergoing IVF/ICSI treatment with high uterine contraction frequency prior to embryo transfer has a higher live birth rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buscopan 20 milligrams/ML Injectable Solution | cases will be randomized to Buscopan group or Normal Saline group, injection will be given 5 minutes prior to embryo transfer |
Timeline
- Start date
- 2020-05-30
- Primary completion
- 2024-04-30
- Completion
- 2024-09-14
- First posted
- 2021-02-11
- Last updated
- 2024-05-08
Locations
1 site across 1 country: Hong Kong
Source: ClinicalTrials.gov record NCT04751084. Inclusion in this directory is not an endorsement.